High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas

Abstract excerpt

PURPOSE Biopsy is the gold standard for the diagnosis of primary CNS lymphoma (PCNSL). However, surgical biopsy has problems of morbidity related to hemorrhagic complications and false-negative findings, so safer and more reliable diagnostic methods are required. The aim of this study is to detect the MYD88 mutation, an important driver mutation, in the cerebrospinal fluid (CSF) of patients with CNS lymphoma....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to CNS Lymphoma Diagnosis and Treatment
• Share to Lymphoma Diagnosis and Treatment